Human subjects research with prisoners: putting the ethical question in context
By Osagie K. Obasogie and Keramet A. Reiter,
Bioethics
| 12. 16. 2010
[Commentary]
We write in response to the conversation initiated in Volume 24.1 of Bioethics, which focused on the role of prisoners in biomedical and behavioral research. As interdisciplinary legal scholars who have researched the history, ethics, and current practices of prison research in the United States, we write to encourage further dialogue about the Institute of Medicine's (IOM) recommendations to reform current standards for prisoners' participation as human subjects. Specifically, we challenge three critical assumptions, which underlie several articles in the Bioethics special issue.
First, we challenge the idea that a risk-benefit assessment applied to prisoner participants in research is too restrictive.1 On the contrary, we argue that it is too permissive. The IOM's risk-benefit proposal – the most significant of its five main recommendations – is designed to relax current standards that categorically restrict prisoners' participation as human subjects to four narrow situations that directly benefit prisoners.2 Current policies were implemented in response to substantial abuses directly connected to prisoners' vulnerability and deplorable prison conditions; a 1976 Commission concluded that widespread research in prisons should not be...
Related Articles
By Annika Inampudi, Science | 08.01.2025
In June, Sara* received a message asking whether she wanted to continue to participate in a massive, multicenter research project led by scientists at Aarhus University in Denmark. The iPsych study, the message said, had sequenced her genetic data from...
The Center for Genetics and Society is delighted to recommend the current edition of GMWatch Review – Number 589. UK-based GMWatch, a long-standing ally, was founded in 1998 by Jonathan Matthews as an independent organization seeking to counter the enormous corporate political power and propaganda of the GMO industry and its supporters. Matthews and Claire Robinson are its directors and managing editors.
CGS works to ensure that social justice, equity, human rights, and democratic governance are front...
By Ryan Cross, Endpoints News | 08.19.2025
Human eggs are incredibly rare cells. The ovary typically produces only 400 mature eggs across a woman’s life. But biologists in George Church’s lab at Harvard University — a group that’s never content with nature’s limits — just got a...
By Riley Beggin and Jeff Stein, The Washington Post | 08.03.2025
The White House does not plan to require health insurers to provide coverage for in vitro fertilization services, two people with knowledge of internal discussions said, even though the idea was one of President Donald Trump’s key campaign pledges.
Last...